Corcept Therapeutics Inc
F:HTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corcept Therapeutics Inc
F:HTD
|
US |
|
CEL-SCI Corp
F:LSRM
|
US |
|
T
|
Thai Airways International PCL
SET:THAI
|
TH |
|
B
|
Beyond Securities PCL
SET:BYD
|
TH |
|
B
|
Boeing Co
XMUN:BCO
|
US |
|
P
|
Paycom Software Inc
F:0PY
|
US |
|
D
|
DoorDash Inc
F:DD2
|
US |
|
G
|
Gen Digital Inc
XMUN:SYM
|
US |
|
D
|
Daiichi Sankyo Co Ltd
XMUN:D4S
|
JP |
|
C
|
Coca-Cola Co
XMUN:CCC3
|
US |
|
Toyota Motor Corp
F:TOM
|
JP |
|
C
|
Cheesecake Factory Inc
F:CF2
|
US |
|
D
|
Discover Financial Services
XBER:DC7
|
US |
|
P
|
Porr AG
XBER:ABS2
|
AT |
Wall St Price Targets
HTD Price Targets Summary
Corcept Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for HTD is 63.69 EUR with a low forecast of 35.83 EUR and a high forecast of 100.57 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HTD's stock price target?
Price Target
63.69
EUR
According to Wall Street analysts, the average 1-year price target for HTD is 63.69 EUR with a low forecast of 35.83 EUR and a high forecast of 100.57 EUR.
What is the Revenue forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Gross Profit forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Operating Income forecast for Corcept Therapeutics Inc?
Projected CAGR
65%
The compound annual growth rate for Operating Income over the next 8 years is 65%.
What is the Pre-Tax Income forecast for Corcept Therapeutics Inc?
Projected CAGR
108%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 108%.
What is the Net Income forecast for Corcept Therapeutics Inc?
Projected CAGR
46%
The compound annual growth rate for Net Income over the next 8 years is 46%.
